VEGF and TWIST1 in a 16-Biomarker Immunoprofile Useful for Prognosis of Breast Cancer Patients

International Journal of Cancer - United States
doi 10.1002/ijc.30868
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

VEGF-B Promotes Cancer Metastasis Through a VEGF-A–independent Mechanism and Serves as a Marker of Poor Prognosis for Cancer Patients

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2015English

Differentially Expressed lncRNAs in Gastric Cancer Patients: A Potential Biomarker for Gastric Cancer Prognosis

Journal of Cancer
Oncology
2017English

Methylation of the TWIST1 Promoter, TWIST1 mRNA Levels, and Immunohistochemical Expression of TWIST1 in Breast Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

Overexpression of HPIP as a Biomarker for Metastasis and Prognosis Prediction in Endometrial Cancer Patients

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2019English

ROR1 Expression as a Biomarker for Predicting Prognosis in Patients With Colorectal Cancer

Oncotarget
Oncology
2017English

MiR-339-5p Inhibits Breast Cancer Cell Migration and Invasion in Vitro and May Be a Potential Biomarker for Breast Cancer Prognosis

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

TRIM29 Suppresses TWIST1 and Invasive Breast Cancer Behavior

Cancer Research
Cancer ResearchOncology
2014English

MDM2 Is a Useful Prognostic Biomarker for Resectable Gastric Cancer

Cancer Science
Cancer ResearchMedicineOncology
2013English

Prognosis of Breast Cancer Patients Underwent Surgery in a Developing Country

Journal of Cancer Therapy
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy